The Cooper Companies, Inc.

COO ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $372.9M $273.9M $203.5M $269.9M $296.2M $248.3M $175.4M $112.8M
Depreciation & Amortization $188.4M $198.3M $191.4M $138.2M $125.3M $111.2M $98.1M $94.0M
Depreciation $120.0M $137.5M $139.9M $102.5M $95.1M $87.2M $77.6M $75.9M
Amortization $68.4M $60.8M $51.5M $35.7M $30.2M $24.0M $20.5M $18.1M
Stock-Based Compensation $37.2M $29.9M $32.9M $36.5M $28.5M $21.5M $13.9M $9.6M
Net Cash from Operating Activities $593.6M $509.6M $390.9M $454.8M $415.9M $315.1M $336.3M $267.7M
Investing Activities
Capital Expenditures $127.2M $152.6M $243.0M $238.1M $178.1M $99.8M $103.7M $73.8M
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-381.3M $-418.7M $-287.9M $-1.35B $-189.9M $-238.5M $-161.7M $-106.6M
Financing Activities
Dividends Paid $2.9M $2.9M $2.9M $2.9M $2.9M $2.9M $2.8M $2.7M
Stock Repurchases $55.0M $0 $67.3M $75.8M $167.3M $71.2M $0 $0
Net Cash from Financing Activities $-227.9M $-1.4M $-106.7M $842.2M $-161.6M $-68.4M $-172.9M $-161.6M
Net Change in Cash $-12.0M $84.4M $-8.8M $-52.2M $64.6M $7.7M $1.6M $-359.0K
Free Cash Flow $466.4M $357.0M $147.9M $216.8M $237.8M $215.3M $232.6M $193.9M
← Newer Page 2 of 3 Older →